CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- 10-Q Report Quarterly Report
- SC 13D Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy 10% owner bought 200,000 shares at $17.00 ($3,400,000)
- 4 Conversion 10% owner acquired 1,596,222 shares (conversion)
- 4 Open-market buy 10% owner bought 400,000 shares at $17.00 ($6,800,000)
- 8-K Event Bylaws or fiscal year change · Other events
- 4 Open-market buy EVP & Chief Financial Officer bought 2,000 shares at $17.00 ($34,000)
- 4 Open-market buy Director bought 200,000 shares at $17.00 ($3,400,000)
- 4 Open-market buy 10% owner bought 700,000 shares at $17.00 ($11,900,000)
- SC 13G Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 424B4 Offering Prospectus
- 4 Derivatives Options or other derivatives
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
Page 24 of 27 · 524 filings